Eva Hoch

2.7k total citations · 1 hit paper
87 papers, 1.4k citations indexed

About

Eva Hoch is a scholar working on Pharmacology, Clinical Psychology and Epidemiology. According to data from OpenAlex, Eva Hoch has authored 87 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pharmacology, 31 papers in Clinical Psychology and 27 papers in Epidemiology. Recurrent topics in Eva Hoch's work include Cannabis and Cannabinoid Research (41 papers), Substance Abuse Treatment and Outcomes (26 papers) and Child and Adolescent Psychosocial and Emotional Development (12 papers). Eva Hoch is often cited by papers focused on Cannabis and Cannabinoid Research (41 papers), Substance Abuse Treatment and Outcomes (26 papers) and Child and Adolescent Psychosocial and Emotional Development (12 papers). Eva Hoch collaborates with scholars based in Germany, Australia and Canada. Eva Hoch's co-authors include Wayne Hall, Ulrich W. Preuss, Bernard Le Foll, Alan J. Budney, Daniel Stjepanović, Jason P. Connor, Valentina Lorenzetti, Miriam Schneider, Chris M. Friemel and Anil Batra and has published in prestigious journals such as Psychological Medicine, Nature Reviews Disease Primers and Addiction.

In The Last Decade

Eva Hoch

76 papers receiving 1.3k citations

Hit Papers

Cannabis use and cannabis use disorder 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cannabis use and cannabis use disorder
    2021 257 citations Jason P. Connor, Daniel Stjepanović et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Hoch Germany 20 867 426 347 264 232 87 1.4k
Malka Stohl United States 13 646 0.7× 422 1.0× 503 1.4× 348 1.3× 253 1.1× 29 2.0k
Evan S. Herrmann United States 20 675 0.8× 266 0.6× 217 0.6× 196 0.7× 82 0.4× 42 1.3k
Dvora Shmulewitz United States 26 897 1.0× 743 1.7× 512 1.5× 481 1.8× 151 0.7× 78 2.1k
Aimee L. Ward New Zealand 10 776 0.9× 301 0.7× 225 0.6× 213 0.8× 189 0.8× 25 1.3k
José Pérez de los Cobos Spain 19 422 0.5× 605 1.4× 275 0.8× 285 1.1× 250 1.1× 64 1.6k
Pamela Sabioni Canada 13 663 0.8× 345 0.8× 158 0.5× 137 0.5× 120 0.5× 19 968
Simon J. Adamson New Zealand 19 655 0.8× 1.3k 2.9× 668 1.9× 508 1.9× 251 1.1× 60 2.3k
Peggy van der Pol Netherlands 16 590 0.7× 374 0.9× 215 0.6× 178 0.7× 92 0.4× 28 860
Victoria R. Votaw United States 18 255 0.3× 683 1.6× 466 1.3× 224 0.8× 172 0.7× 51 1.8k
Marc L. Copersino United States 24 660 0.8× 700 1.6× 312 0.9× 268 1.0× 444 1.9× 42 2.0k

Countries citing papers authored by Eva Hoch

Since Specialization
Citations

This map shows the geographic impact of Eva Hoch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hoch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hoch more than expected).

Fields of papers citing papers by Eva Hoch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Hoch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hoch. The network helps show where Eva Hoch may publish in the future.

Co-authorship network of co-authors of Eva Hoch

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Hoch. A scholar is included among the top collaborators of Eva Hoch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Hoch. Eva Hoch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rumpf, Hans‐Jürgen, Anil Batra, Eva Hoch, et al.. (2025). Guidelines on Internet Use Disorders: Introduction and Methodology. SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice. 71(2). 73–78. 4 indexed citations
2.
Hoch, Eva, et al.. (2025). Cannabis use disorder: an overview of treatment approaches in Europe. European Archives of Psychiatry and Clinical Neuroscience. 275(2). 315–326.
3.
Hoch, Eva, et al.. (2025). DAILY – A personalized circadian Zeitgeber therapy as an adjunctive treatment for alcohol use disorder patients: results of a pilot trial. Frontiers in Psychiatry. 16. 1477895–1477895. 4 indexed citations
4.
Olderbak, Sally, et al.. (2025). Estimates of Driving under the Influence of Cannabis in Germany in 2021 before the Partial Legalization. SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice. 71(1). 31–38.
5.
Schwarzkopf, Larissa, et al.. (2024). Cannabis-related treatment demand at the eve of German cannabis legalization – a 20-years trend analysis. European Archives of Psychiatry and Clinical Neuroscience. 275(2). 365–378.
6.
Pogarell, Oliver, et al.. (2024). Short-term effectiveness of the national German quitline for smoking cessation: results of a randomized controlled trial. BMC Public Health. 24(1). 588–588. 1 indexed citations
7.
Kotz, Daniel, et al.. (2024). Cannabis use in Germany: Frequency, routes of administration, and co-use of inhaled nicotine or tobacco products. Deutsches Ärzteblatt international. 121(2). 52–57. 6 indexed citations
8.
Fischer, Benedikt, Wayne Hall, Thiago Marques Fidalgo, et al.. (2023). Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes: A Public Mental Health-Oriented Evidence Review. Journal of Dual Diagnosis. 19(2-3). 71–96. 12 indexed citations
9.
Nowak, Dennis, et al.. (2022). Cannabidiol As a Treatment for COVID-19 Symptoms? A Critical Review. Cannabis and Cannabinoid Research. 8(3). 487–494. 3 indexed citations
10.
Pogarell, Oliver, et al.. (2022). Effectiveness of the national German quitline for smoking cessation: study protocol of a randomized controlled trial. BMC Public Health. 22(1). 1386–1386. 2 indexed citations
11.
Connor, Jason P., Daniel Stjepanović, Bernard Le Foll, et al.. (2021). Cannabis use and cannabis use disorder. Nature Reviews Disease Primers. 7(1). 16–16. 257 indexed citations breakdown →
12.
Preuss, Ulrich W., Marilyn A. Huestis, Miriam Schneider, et al.. (2021). Cannabis Use and Car Crashes: A Review. Frontiers in Psychiatry. 12. 643315–643315. 44 indexed citations
13.
Raabe, Florian J., Elias Wagner, David Popovic, et al.. (2020). Classical blood biomarkers identify patients with higher risk for relapse 6 months after alcohol withdrawal treatment. European Archives of Psychiatry and Clinical Neuroscience. 271(5). 891–902. 4 indexed citations
14.
Havemann‐Reinecke, Ursula, Eva Hoch, Ulrich W. Preuss, et al.. (2017). [On the legalization debate of non-medical cannabis consumption : Position paper of the German Association for Psychiatry, Psychotherapy and Psychosomatics].. PubMed. 88(3). 291–298. 5 indexed citations
15.
Preuss, Ulrich W., Euphrosyne Gouzoulis‐Mayfrank, Ursula Havemann‐Reinecke, et al.. (2017). Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines. European Archives of Psychiatry and Clinical Neuroscience. 268(3). 219–229. 25 indexed citations
16.
Soyka, Michael, Ulrich W. Preuss, & Eva Hoch. (2017). Cannabisinduzierte Störungen. Der Nervenarzt. 88(3). 311–325. 2 indexed citations
17.
Hoch, Eva, Ulrich W. Preuss, Marica Ferri, & Roland Simon. (2016). Digital Interventions for Problematic Cannabis Users in Non-Clinical Settings: Findings from a Systematic Review and Meta-Analysis. European Addiction Research. 22(5). 233–242. 54 indexed citations
18.
Hoch, Eva, et al.. (2013). CANDIS treatment program for cannabis use disorders: Findings from a randomized multi-site translational trial. Drug and Alcohol Dependence. 134. 185–193. 49 indexed citations
19.
Hoch, Eva, et al.. (2011). Efficacy of a targeted cognitive–behavioral treatment program for cannabis use disorders (CANDIS*). European Neuropsychopharmacology. 22(4). 267–280. 34 indexed citations
20.
Hoch, Eva. (1959). Some problems of mental health in India.. PubMed. 34(2). 81–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malka Stohl Breakdown of academic impact, for papers by Evan S. Herrmann Breakdown of academic impact, for papers by Dvora Shmulewitz Breakdown of academic impact, for papers by Aimee L. Ward Breakdown of academic impact, for papers by José Pérez de los Cobos Breakdown of academic impact, for papers by Pamela Sabioni Breakdown of academic impact, for papers by Simon J. Adamson Breakdown of academic impact, for papers by Peggy van der Pol Breakdown of academic impact, for papers by Victoria R. Votaw Breakdown of academic impact, for papers by Marc L. Copersino
Rankless by CCL
2026